MedTrace Logo

Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology

NCT05768776 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-06-25

No results posted yet for this study

Summary

The aim of this study is to compare the success rate of outpatient surgery after holmium LASER enucleation of the prostate (HoLEP) for the treatment of BPH with and without the use of the MOSES 2.0 effect.

Conditions

  • Benign Prostatic Hypertrophy
  • Holmium Laser Enucleation of the Prostate

Interventions

PROCEDURE

HoLEP patients without MOSES(TM) 2.0 effect (open label)

HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, without using MOSES technology

PROCEDURE

HoLEP patients with MOSES(TM) 2.0 effect (open label)

HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, with the use of MOSES technology

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Grégoire ROBERT, PU-PH · University Hospital Bordeaux, France

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768776 on ClinicalTrials.gov